Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Valuation vs Instaport thresholds (P/E, PEG, P/FCF, P/S)
Licensed market data — shown to members, not published to the open web.
Profile
From SEC filingsAt a glance
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- CEO
- Kevin R. Lind Name
- Employees (2026)
- 65
- Incorporated in
- DE
Sector is derived from the SEC industry classification.
39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, United States · 617-500-8880 · apnimed.com
News Intelligence (AI brief)
Included with Pro.
Source: SEC filings. Information and analytics, not investment advice.